NeuroMetrix Inc. is a healthcare company that specializes in developing advanced medical technologies to improve the management of chronic pain and diabetes-related conditions
Their innovative products include non-invasive diagnostic and therapeutic devices that utilize neurostimulation and electrophysiology. By focusing on enhancing patient outcomes, the company aims to provide healthcare professionals with tools that facilitate accurate diagnosis and effective treatment strategies, ultimately alleviating the burden of pain and improving the quality of life for individuals suffering from these chronic conditions.
Gainers NeuroBo Pharmaceuticals (NASDAQNRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million.
Gainers DICE Therapeutics (NASDAQDICE) stock moved upwards by 83.4% to $45.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.7 billion.
Gainers NeuroMetrix (NASDAQNURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million.
Gainers M-tron Industries, Inc. (NASDAQMPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group, Inc.
Gainers Applied DNA Sciences, Inc. (NASDAQAPDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the mid-six-figures.
